Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
New Agent for Biliary Tract Cancer Approved
The U.S. Food and Drug Administration (FDA) has approved zanidatamab (Ziihera, Jazz Pharmaceuticals, Inc.) as monotherapy for previously treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC). This approval makes the bispecific antibody the first HER2-targeted treatment to carry the…
English